Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation. 1990

G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
Department of Medicine, College of Medicine, J. Hillis Miller Health Center, University of Florida, Gainesville.

Cytomegalovirus (CMV) interstitial pneumonia is a frequent and often fatal complication of allogeneic bone marrow transplantation. Because therapy for CMV pneumonia was, until recently, largely ineffective, prophylactic methods were explored. This study shows that the strategy of using CMV seronegative blood products for seronegative patients with seronegative donors or weekly administration of intravenous immunoglobulin for all other patients reduced the attack rate of CMV pneumonia. The results of this study are put into the perspective of previously published data.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007223 Infant A child between 1 and 23 months of age. Infants
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
January 1990, Cancer treatment and research,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
January 1987, Annals of internal medicine,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
September 1990, Nihon rinsho. Japanese journal of clinical medicine,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
February 1975, Annals of internal medicine,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
August 2000, Bone marrow transplantation,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
May 1980, The Journal of infectious diseases,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
January 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
May 1973, Transplantation,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
December 1984, Japanese journal of clinical oncology,
G J Elfenbein, and T Siddiqui, and K H Rand, and J Graham-Pole, and R B Marcus, and N P Mendenhall, and T M Goedert, and T Wikle-Fisher, and S A Gross, and R S Weiner
May 1994, Blood,
Copied contents to your clipboard!